UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Discovery of the cancer stem cell related determinants of radioresistance

Radiotherapy and oncology, 2013-09, Vol.108 (3), p.378-387

2013

Link zum Volltext

Verfügbarkeit prüfen

What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond

Molecular oncology, 2020-07, Vol.14 (7), p.1577-1585

2020

Link zum Volltext

Verfügbarkeit prüfen

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L

Oncogene, 2021-06, Vol.40 (24), p.4214-4228

2021

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma

Oncotarget, 2015-10, Vol.6 (33), p.34494-34509

2015

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response

Frontiers in oncology, 2021-03, Vol.10, p.627379

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting Cancer Stem Cells: Promises and Challenges

Anti-cancer agents in medicinal chemistry, 2016-01, Vol.16 (1), p.38

2016

Link zum Volltext

Verfügbarkeit prüfen

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

Clinical cancer research, 2019-05, Vol.25 (10), p.3152-3163

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts

Journal of translational medicine, 2023-08, Vol.21 (1), p.1-576, Article 576

2023

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer

Cancers, 2024-02, Vol.16 (4), p.730

2024

Link zum Volltext

Verfügbarkeit prüfen

Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

Molecular oncology, 2023-12, Vol.17 (12), p.2618-2636

2023

Link zum Volltext

Verfügbarkeit prüfen

Enhancing mass spectrometry imaging accessibility using convolutional autoencoders for deriving hypoxia-associated peptides from tumors

NPJ systems biology and applications, 2024-05, Vol.10 (1), p.57-57, Article 57

2024

Link zum Volltext

Verfügbarkeit prüfen

The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence

Cancers, 2024-01, Vol.16 (2), p.439

2024

Link zum Volltext

Verfügbarkeit prüfen

A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment

Cancers, 2023-03, Vol.15 (6), p.1655

2023

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

Cancers, 2021-04, Vol.13 (8), p.1865

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells

Journal of Cancer, 2016-01, Vol.7 (6), p.736-745

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer stem cells in radiation response: current views and future perspectives in radiation oncology

International journal of radiation biology, 2019-07, Vol.95 (7), p.900-911

2019

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia as a biomarker for radioresistant cancer stem cells

International journal of radiation biology, 2014-08, Vol.90 (8), p.636-652

2014

Link zum Volltext

Verfügbarkeit prüfen

Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells

Cancer research (Chicago, Ill.), 2015-04, Vol.75 (7), p.1482-1494

2015

Link zum Volltext

Verfügbarkeit prüfen

Cancer biomarker discovery: Current status and future perspectives

International journal of radiation biology, 2014-08, Vol.90 (8), p.659-677

2014

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer

Radiotherapy and oncology, 2024-05, p.110348, Article 110348

2024

Link zum Volltext

Verfügbarkeit prüfen

New insights into RAS in head and neck cancer

Biochimica et biophysica acta. Reviews on cancer, 2023-11, Vol.1878 (6), p.188963-188963, Article 188963

2023

Link zum Volltext

Verfügbarkeit prüfen

CXCR4 as biomarker for radioresistant cancer stem cells

International journal of radiation biology, 2014-08, Vol.90 (8), p.687-699

2014

Link zum Volltext

Verfügbarkeit prüfen

High‐Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance

International journal of cancer, 2022-02, Vol.150 (4), p.663-677

2022

Link zum Volltext

Verfügbarkeit prüfen

Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma

Molecular cancer research, 2021-10, Vol.19 (10), p.1676-1687

2021

Link zum Volltext

Verfügbarkeit prüfen

HGG-38. COMBINING TARGETED THERAPY AND RADIATION OUTPERFORMS SINGLE TREATMENTS IN PEDIATRIC HIGH-GRADE GLIOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Supplement_4), p.0-0

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Discovery of the cancer stem cell related determinants of radioresistance

What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response

Targeting Cancer Stem Cells: Promises and Challenges

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts

Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer

Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

Enhancing mass spectrometry imaging accessibility using convolutional autoencoders for deriving hypoxia-associated peptides from tumors

The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence

A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells

Cancer stem cells in radiation response: current views and future perspectives in radiation oncology

Hypoxia as a biomarker for radioresistant cancer stem cells

Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells

Cancer biomarker discovery: Current status and future perspectives

Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer

New insights into RAS in head and neck cancer

CXCR4 as biomarker for radioresistant cancer stem cells

High‐Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance

Establishment of a Plasticity-Associated Risk Model Based on a SOX2- and SOX9-Related Gene Set in Head and Neck Squamous Cell Carcinoma

HGG-38. COMBINING TARGETED THERAPY AND RADIATION OUTPERFORMS SINGLE TREATMENTS IN PEDIATRIC HIGH-GRADE GLIOMA

Suchergebnisse filtern